Abstract:The concepts of transcriptional intratumor heterogeneity and phenotypic plasticity have gained significant attention in relation to the development of tumor resistance to cancer treatments [1]. In several cancer types, recent studies have linked certain somatic genomic aberrations to the presence of specific transcriptional states in malignant cells [2,3]. However, our general understanding of drivers of epigenetic and transcriptional plasticity stays somewhat fragmented. In theory, this gap could be filled through the generation and analysis of single-cell multi-omics datasets of human tumors coupled with clinical information. In practice, such datasets are pretty scarce, and existing data certainly do not allow for a global analysis of the genetic drivers of cell plasticity and heterogeneity across cancer types. On the other hand, the scientific community has already generated rich bulk transcriptomics datasets coupled with genetic and clinical information (e.g., TCGA) that could be used to answer the question about the relationship between genetic and epigenetic landscapes if proportions of cells in different malignant states could be extracted via a computational deconvolution of the transcriptomic signal. Unfortunately, available methods for accurate bulk data deconvolution require reference single-cell transcriptomics datasets, which limits the applicability of such approaches to study large pan-cancer datasets. We provide a solution to this problem by creating and benchmarking an algorithmic approach that allows extracting the transcriptional heterogeneity information from bulk tumor profiles without the need for a single-cell reference when a matched DNA-sequencing experiment is available. The latter is true for thousands of tumor samples, including all TCGA datasets. We present results of a pan-cancer analysis linking genetic aberrations with proportions of malignant cells in specific transcriptional states that shed light on the potential genetic drivers underlying malignant cell heterogeneity. References 1. Boeva, V. et al. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat. Genet. 49, 1408–1413 (2017). 2. Neftel, C. et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178, 835-849.e21 (2019). 3. Moorman, A. R. et al. Progressive plasticity during colorectal cancer metastasis. BioRxiv Prepr. Serv. Biol. 2023.08.18.553925 (2023) doi:10.1101/2023.08.18.553925. Citation Format: Agnieszka Kraft, Josephine Yates, Florian Barkmann, Valentina Boeva. Unraveling potential genetic drivers of intratumor transcriptional heterogeneity and phenotypic plasticity in malignant cells [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2) nr IA024.

Epigenomic heterogeneity as a source of tumour evolution

Epigenetic Heterogeneity in Cancer

Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Tumour heterogeneity and resistance to cancer therapies

Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior

Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy

Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

Clinical implications of intratumor heterogeneity: challenges and opportunities

Using Single‐cell Multiple Omics Approaches to Resolve Tumor Heterogeneity

Abstract IA024: Unraveling potential genetic drivers of intratumor transcriptional heterogeneity and phenotypic plasticity in malignant cells

Molecular heterogeneity in breast cancer: State of the science and implications for patient care

A population genetics perspective on the determinants of intra-tumor heterogeneity

Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance

Cellular Heterogeneity and Molecular Evolution in Cancer

Role of Epigenetics in Lung Cancer Heterogeneity and Clinical Implication.

Epigenetic tumor heterogeneity in the era of single-cell profiling with nanopore sequencing

Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications

Nongenetic evolution of the tumor: from challenges to new therapeutic opportunities

Recurrence of cancer cell states across diverse tumors and their interactions with the microenvironment